Table of Contents
ISRN Oncology
Volume 2012, Article ID 163752, 15 pages
http://dx.doi.org/10.5402/2012/163752
Review Article

Biologic Therapy in Head and Neck Cancer: A Road with Hurdles

Department of Medical Oncology, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium

Received 11 March 2012; Accepted 11 April 2012

Academic Editors: A. Celetti, K. J. Dornfeld, and F. Kuhnel

Copyright © 2012 Pol Specenier and Jan B. Vermorken. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Alessandro Gonfiotti, Massimo Osvaldo Jaus, Daniel Barale, and Paolo Macchiarini, “Extensive Tracheal Necrosis After Treatment of Anaplastic Thyroid Cancer With Vascular Endothelial Growth Factor Inhibitors,” Annals Of Thoracic Surgery, vol. 95, no. 6, pp. 2181–2181, 2013. View at Publisher · View at Google Scholar
  • Muneyuki Masuda, Satoshi Toh, Takahiro Wakasaki, Masumi Suzui, and Andrew K. Joe, “Somatic evolution of head and neck cancer - Biological robustness and latent vulnerability,” Molecular Oncology, vol. 7, no. 1, pp. 14–28, 2013. View at Publisher · View at Google Scholar
  • Lale Kostakoglu, Reza Fardanesh, Marshall Posner, Peter Som, Srikar Rao, Eunice Park, John Doucette, Evan Stein, Vishal Gupta, Krzysztof Misiukiewicz, and Eric Genden, “Early Detection of Recurrent Disease by FDG-PET/CT Leads to Management Changes in Patients With Squamous Cell Cancer of the Head and Neck,” Oncologist, vol. 18, no. 10, pp. 1108–1117, 2013. View at Publisher · View at Google Scholar
  • Pol Specenier, and Jan B Vermorken, “Cetuximab: its unique place in head and neck cancer treatment.,” Biologics : targets & therapy, vol. 7, pp. 77–90, 2013. View at Publisher · View at Google Scholar
  • Sebastian Strieth, Christoph Dunau, Uwe Michaelis, Lorenz Jaeger, Donata Gellrich, Barbara Wollenberg, and Marc Dellian, “Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer,” Head and Neck-Journal for The Sciences and Specialties of The Head and Neck, vol. 36, no. 7, pp. 976–984, 2014. View at Publisher · View at Google Scholar
  • Anja Pickhard, Guido Piontek, Christof Seidl, Samuel Kopping, Birgit Blechert, Martin Misslbeck, Gero Brockhoff, Frank Bruchertseifer, Alfred Morgenstern, and Markus Essler, “Bi-213-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells,” Nuclear Medicine and Biology, vol. 41, no. 1, pp. 68–76, 2014. View at Publisher · View at Google Scholar
  • Shellese A Cannonier, Cara B Gonzales, Kim Ely, Scott A Guelcher, and Julie A Sterling, “Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.,” Oncotarget, vol. 7, no. 46, pp. 76062–76075, 2016. View at Publisher · View at Google Scholar
  • Nur Syafinaz Zainal, Gan Chai Phei, Lau Beng Fye, Yee Pei San, Tiong Kai Hung, Zainal Ariff Abdul Rahman, Vyomesh Patel, and Sok Ching Cheong, “Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells,” Phytomedicine, 2017. View at Publisher · View at Google Scholar
  • Paolo Bossi, and Francesca Platini, “Radiotherapy plus EGFR inhibitors: synergistic modalities,” Cancers of the Head & Neck, vol. 2, no. 1, 2017. View at Publisher · View at Google Scholar
  • Anna Kiseleva, Tim N. Beck, Ilya G. Serebriiskii, Hanqing Liu, Barbara Burtness, and Erica A. Golemis, “Targeting the ErbB Family in Head and Neck Cancer,” Molecular Determinants of Head and Neck Cancer, pp. 7–61, 2018. View at Publisher · View at Google Scholar
  • Eleonore Longton, Kathleen Schmit, Maude Fransolet, François Clement, and Carine Michiels, “Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma,” Frontiers in Oncology, vol. 8, 2018. View at Publisher · View at Google Scholar